Sveriges mest populära poddar
The Long Run with Luke Timmerman
Vetenskap

Ep135: John Maraganore on Developing a New Class of Medicines

1 tim 4 min•8 maj 2023
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.

Fler avsnitt av The Long Run with Luke Timmerman

Visa alla avsnitt av The Long Run with Luke Timmerman
Ep198: Abbas Kazimi on Computation and Culture for Drug Discovery
•1 tim 17 min
Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature
•1 tim 17 min
Ep196: Otello Stampacchia on Europe's Biotech Crisis
•1 tim 3 min
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
•1 tim 6 min
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery
•1 tim 9 min
Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
•1 tim 5 min
Ep192: Kate Haviland on Following the Science to Precision Immunology
•1 tim 26 min
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
•1 tim 8 min
Ep190: Neil Kumar on Building a Rare Disease Drug Company
•1 tim 13 min
Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI
•1 tim 13 min

The Long Run with Luke Timmerman med Timmerman Report finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.